Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Prostate screening may have benefits

Cancer Research UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage.

1 Apr 2009

Protein ferritin in blood may hold key to stopping tumor growth in cancer patients

A recent discovery by researchers at Wake Forest University School of Medicine could clear the way for a new drug that inhibits tumor growth in cancer patients and could potentially help in the healing of wounds.

1 Apr 2009

Scientists develop molecular system that amplifies certain events

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques.

30 Mar 2009

Discovery of new biomarker for prostate cancer

Researchers at Wayne State University have identified a new marker for prostate cancer progression that may one day lead to new treatments.

26 Mar 2009

Number of Alzheimer's cases growing annually, increasing costs, report finds

The number of U.S. residents with Alzheimer's disease is increasing annually, putting more pressure on the health care system, according to a report issued on Tuesday by the Alzheimer's Association, USA Today reports (Brophy Marcus, USA Today, 3/24).

25 Mar 2009

New approach to prostate cancer detection - Sarcosine may distinguish between slow-growing and aggressive prostate cancers

On Friday 20 March, US researcher Dr. Chris Beecher from the University of Michigan gave a well attended lecture about sarcosine, an N-methyl derivative of the amino acid glycine, at the 24th Annual EAU Congress in Stockholm, Sweden.

25 Mar 2009

Ovarian cancers detected early may be less aggressive, questioning effectiveness of screening

The biology of ovarian cancers discovered at an early stage may render them slower growing and less likely to spread than more aggressive cancers, which typically are discovered in an advanced stage, according to a study led by investigators in the Duke Comprehensive Cancer Center.

24 Mar 2009

Omega-3 fatty acids appear protective against advanced prostate cancer

Omega-3 fatty acids appear protective against advanced prostate cancer, and this effect may be modified by a genetic variant in the COX-2 gene, according to a report in Clinical Cancer Research , a journal of the American Association for Cancer Research.

24 Mar 2009

More cancer patients cured according to new data on cancer survival in Europe

New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer - rather than just surviving for at least five years after diagnosis - is rising steadily.

23 Mar 2009

Belfast gets new cancer centre

Belfast joins a unique chain of Cancer Research UK Centres that are being launched across the UK.

23 Mar 2009

Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment

Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.

23 Mar 2009

New nanotechnology treatment for drug addiction

A precise, new nanotechnology treatment for drug addiction may be on the horizon as the result of research conducted at the University at Buffalo.

23 Mar 2009

Trial update on watchful waiting versus radical prostatectomy

In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up.

22 Mar 2009

New therapeutic approaches to castrate resistant prostate cancer

Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24 th Annual Congress of the European Association of Urology in Stockholm, Sweden.

22 Mar 2009

PSA screening delivers a 20% reduction in mortality from prostate cancer

Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online in at NEJM, Online First.

20 Mar 2009

Improvements in prostate cancer recognition, management and treatment are needed

The prostate cancer charter for change from 13 influential European and US prostate cancer patient groups, calls for the disease to be treated with the same level of priority as breast cancer is in women.

20 Mar 2009

Prostate cancer expert say keep screening in face of contradicting data

New data evaluating the impact of screening on mortality provides mixed messages on the value of prostate cancer screening.

20 Mar 2009

Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment

A multi-center study of prostate cancer patients appearing in today's Journal of Urology recommends that for some men diagnosed with low-risk prostate cancer, opting not to initially receive treatment can be safe if they are closely monitored.

16 Mar 2009

Identification of triggering mechanism by which breast and prostate cancer cells begin

Dr. Ercole Cavalieri and Dr. Eleanor Rogen of the University of Nebraska Medical Center, Eppley Institute for Research in Cancer, located in Omaha, Nebraska, have identified the triggering mechanism by which breast and prostate cancer cells begin. Preventium is a recently developed dietary supplement that promises to reduce people's risk for breast and prostate cancer.

16 Mar 2009

Promising results for 5-day stereotactic body radiation therapy in early stage prostate cancer

Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics , the official journal of the American Society for Radiation Oncology (ASTRO).

16 Mar 2009

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Prostate screening may have benefits

Protein ferritin in blood may hold key to stopping tumor growth in cancer patients

Scientists develop molecular system that amplifies certain events

Discovery of new biomarker for prostate cancer

Number of Alzheimer's cases growing annually, increasing costs, report finds

New approach to prostate cancer detection - Sarcosine may distinguish between slow-growing and aggressive prostate cancers

Ovarian cancers detected early may be less aggressive, questioning effectiveness of screening

Omega-3 fatty acids appear protective against advanced prostate cancer

More cancer patients cured according to new data on cancer survival in Europe

Belfast gets new cancer centre

Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment

New nanotechnology treatment for drug addiction

Trial update on watchful waiting versus radical prostatectomy

New therapeutic approaches to castrate resistant prostate cancer

PSA screening delivers a 20% reduction in mortality from prostate cancer

Improvements in prostate cancer recognition, management and treatment are needed

Prostate cancer expert say keep screening in face of contradicting data

Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment

Identification of triggering mechanism by which breast and prostate cancer cells begin

Promising results for 5-day stereotactic body radiation therapy in early stage prostate cancer

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in